INTERNATIONAL PATENT: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS, JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG FILES APPLICATION FOR "COMBINATION OF ANTI-PLATELET THERAPY ANTI-GPIBΑ WITH IMMUNOTHERAPY FOR CANCER"

GENEVA, Aug. 25 -- DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (Im Neuenheimer Feld 28069120 Heidelberg), JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG (Sanderring 297070 Wurzburg) filed a patent application (PCT/EP2025/054025) for "COMBINATION OF ANTI-PLATELET THERAPY ANTI-GPIbAlpha WITH IMMUNOTHERAPY FOR CANCER" on Feb 14, 2025. With publication no. WO/2025/172530, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HEIKENWALDER, Mathias (Deutsches Krebsforschungszentrum Stiftung des offentlichen RechtsT010 ...